August 07, 2012; 79 (6) Special Article
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Melissa J. Armstrong, Janis M. Miyasaki
First published July 18, 2012, DOI: https://doi.org/10.1212/WNL.0b013e318263c443
Melissa J. Armstrong
From the Department of Neurology (M.J.A.), University of Maryland, Baltimore; Toronto Western Hospital Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease (J.M.M.), Toronto; and Department of Medicine (Neurology) (J.M.M.), University of Toronto, Toronto, Canada.
Janis M. Miyasaki
From the Department of Neurology (M.J.A.), University of Maryland, Baltimore; Toronto Western Hospital Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease (J.M.M.), Toronto; and Department of Medicine (Neurology) (J.M.M.), University of Toronto, Toronto, Canada.
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease [RETIRED]
Report of the Guideline Development Subcommittee of the American Academy of Neurology
Melissa J. Armstrong, Janis M. Miyasaki
Neurology Aug 2012, 79 (6) 597-603; DOI: 10.1212/WNL.0b013e318263c443
Citation Manager Formats
Make Comment
See Comments

Letters: Rapid online correspondence
- Author response
- Melissa J Armstrong, Assistant Professor of Neurology, University of Marylandguidelines@aan.com
- Janis Miyasaki, Toronto, ON, Canada
Submitted September 05, 2012 - Pharmacologic treatment of chorea in Huntington disease
- Oksana Suchowersky, Profess or Medicine - Neurology, University of Alberta Oksana.Suchowersky@albertahealthservices.ca
- Edmonton, Alberta, Canada
Submitted August 28, 2012
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study
Dr. Robert Shapiro and Dr. Amynah Pradhan